<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Talley Ratliff | Activity</title>
	<link>https://www.catswannabecats.com/members/periodiran72/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/periodiran72/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Talley Ratliff.</description>
	<lastBuildDate>Tue, 07 Jul 2026 09:45:31 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ab1853c073cf77051a02473046ffa887</guid>
				<title>Talley Ratliff posted an update: Academic respondents were more likely to prescribe an [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12349/</link>
				<pubDate>Sun, 01 Jun 2025 09:18:17 -0400</pubDate>

									<content:encoded><![CDATA[<p>Academic respondents were more likely to prescribe an anti-estrogen medication to symptomatic patients and prophylactically(p less then 0.05). Anastrozole was the most common medication prescribed for symptomatic hyperestrogenemia (62.3%), but starting doses varied significantly, from 1mg weekly to 1mg daily. CONCLUSIONS Approximately 50% of&hellip;<span class="activity-read-more" id="activity-read-more-12349"><a href="https://www.catswannabecats.com/activity/p/12349/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">14694ec1c19ae9cb07d1eca43c5a09fc</guid>
				<title>Talley Ratliff posted an update: This effect ultimately suppressed the induction of c-Fos and [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10712/</link>
				<pubDate>Sun, 01 Jun 2025 02:32:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>This effect ultimately suppressed the induction of c-Fos and NFATc1, which consequently downregulated the expression of the genes required for osteoclast formation and bone resorption. Consistent with our in vitro findings, in vivo administration of Vin protected mice against ovariectomy (OVX)-induced bone loss and trabecular bone deterioration.&hellip;<span class="activity-read-more" id="activity-read-more-10712"><a href="https://www.catswannabecats.com/activity/p/10712/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7b60c64ba3df278273c6e98aa7c29757</guid>
				<title>Talley Ratliff became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9428/</link>
				<pubDate>Sat, 31 May 2025 22:40:46 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>